These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16037653)

  • 1. [Use of neuropsychological tests in the Cronos Project].
    Bianchi G; Gasparini M; Caffari B; Sorrentino GC; Bianchi C; Bruno G; Maggini M; Raschetti R; Vanacore N
    Ann Ist Super Sanita; 2005; 41(1):69-74. PubMed ID: 16037653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The characteristics of Alzheimer's Disease Units in relation to neuropsychological tests].
    Sorrentino GC; Caffari B; Vanacore N; Maggini M; Raschetti R
    Ann Ist Super Sanita; 2005; 41(1):63-8. PubMed ID: 16037652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dementias: mostly clinico-neuropsychological or mostly psychometric diagnosis?].
    Spinnler H
    Ann Ist Super Sanita; 2005; 41(1):75-80. PubMed ID: 16037654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galantamine improves gait performance in patients with Alzheimer's disease.
    Assal F; Allali G; Kressig RW; Herrmann FR; Beauchet O
    J Am Geriatr Soc; 2008 May; 56(5):946-7. PubMed ID: 18454755
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of Alzheimer's disease treatment: the Italian CRONOS project.
    Bianchetti A; Padovani A; Trabucchi M
    Int J Geriatr Psychiatry; 2003 Jan; 18(1):87-8. PubMed ID: 12497562
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 8. [Discriminatory validity and association of the mini-mental test (MMSE) and the memory alteration test (M@T) with a neuropsychological battery in patients with amnestic mild cognitive impairment and Alzheimer's disease].
    Rami L; Bosch B; Valls-Pedret C; Caprile C; Sánchez-Valle Díaz R; Molinuevo JL
    Rev Neurol; 2009 Aug 16-31; 49(4):169-74. PubMed ID: 19621317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease.
    Alberici A; Geroldi C; Cotelli M; Adorni A; Calabria M; Rossi G; Borroni B; Padovani A; Zanetti O; Kertesz A
    Neurol Sci; 2007 Apr; 28(2):80-6. PubMed ID: 17464470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["7 Minute Screening. Part II: the evaluation of the test sensitivity and specificity as compared to Mini-Mental State examination].
    Sobów TM; Maczkiewicz M; Magierski R; Strzelecki D; Wojtera M; Karlińska I; Kłoszewska I
    Psychiatr Pol; 2001; 35(3):475-81. PubMed ID: 11490881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Memantine (Ebixa) in clinical practice - results of an observational study.
    Calabrese P; Essner U; Forstl H
    Dement Geriatr Cogn Disord; 2007; 24(2):111-7. PubMed ID: 17622714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring cognitive change in Alzheimer's disease clinical drug trials.
    Harrison JE
    J Nutr Health Aging; 2007; 11(4):327-9. PubMed ID: 17653492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Early diagnosis and therapy of Alzheimer dementia. Careful documentation prevents degeneration].
    Kohler J; Riepe MW; Jendroska K; Pilartz H; Adler G; Berger FM; Calabrese P; Frölich L; Gertz HJ; Hampel H; Haupt M; Mielke R; Paulus HJ; Zedlick D
    MMW Fortschr Med; 2002 Nov; 144(47):53-4. PubMed ID: 12532523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A
    Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric outcome for clinical trials.
    Robert P; Verhey FR; Aalten P; Cortes F; Byrne EJ
    J Nutr Health Aging; 2007; 11(4):345-7. PubMed ID: 17653496
    [No Abstract]   [Full Text] [Related]  

  • 18. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two dimensions of anosognosia in patients with Alzheimer's disease: reliability and validity of the Japanese version of the Anosognosia Questionnaire for Dementia (AQ-D).
    Sato J; Nakaaki S; Murata Y; Shinagawa Y; Matsui T; Hongo J; Tatsumi H; Akechi T; Furukawa TA
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):672-7. PubMed ID: 18081630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six and 18-month changes in mild to moderate Alzheimer's patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials?
    Cortes F; Portet F; Touchon J; Vellas B
    J Nutr Health Aging; 2007; 11(4):330-7. PubMed ID: 17653493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.